Holen Sie sich die Stockscreener-App
5.79
4.77%
-0.29
Handel nachbörslich:
5.79
Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten
What drives Treace Medical Concepts Inc. stock priceUnmatched profit growth - Autocar Professional
What analysts say about Treace Medical Concepts Inc. stockRecord-breaking capital gains - Autocar Professional
Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigating Claims on Your - GlobeNewswire
Treace Medical Concepts Inc. Stock Analysis and ForecastBreakthrough investment results - jammulinksnews.com
Is Treace Medical Concepts Inc. a good long term investmentHigh-yield growth strategies - Autocar Professional
Important Notice to Long-Term Shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR); Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigatin - GlobeNewswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by Kornitzer Capital Management Inc. KS - MarketBeat
Important Notice to Long-Term Shareholders of Centene - GlobeNewswire
What makes Treace Medical Concepts Inc. stock price move sharplyReal Time Breakout Tracking - Newser
Why Treace Medical Concepts Inc. stock attracts strong analyst attentionFree Access to Community - Newser
How Treace Medical Concepts Inc. stock performs during market volatilitySafer Investing With Bigger Upside - Newser
Important Notice to Long-Term Shareholders of Methode - GlobeNewswire
Important Notice to Long-Term Shareholders of Methode Electronics, Inc. (NYSE: MEI); Manhattan Associates, Inc. (NASDAQ: MANH); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Offi - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Connect - ACCESS Newswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.16 Consensus PT from Analysts - MarketBeat
Important Notice to Long-Term Shareholders of CorMedix Inc. - GlobeNewswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of “Hold” by Analysts - Defense World
Lisanti Capital Growth LLC Buys Shares of 252,215 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Notice to Long-Term Shareholders of Maison Solutions Inc. - GlobeNewswire
Star Tribune - FinancialContent
Notice to Long-Term Shareholders of MicroStrategy, Inc. - GlobeNewswire
Notice to Long-Term Shareholders of DoubleVerify Holdings, - GlobeNewswire
Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) is favoured by institutional owners who hold 53% of the company - Yahoo Finance
Notice to Long-Term Shareholders of Manhattan Associates, - GlobeNewswire
Treace Sues Zimmer and Paragon 28 Over Patents - Orthopedics This Week
Notice to Long-Term Shareholders of Blue Ridge Bankshares, - GlobeNewswire
In the wake of Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) latest US$46m market cap drop, institutional owners may be forced to take severe actions - simplywall.st
Pittsburgh Post-Gazette - FinancialContent
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Maison Solutions Inc. (NASDAQ: MSS); Methode Electronics, Inc. (NYSE: MEI); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Xponential Fitness Inc. (NYSE: XPOF) - Business Upturn
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target at $10.16 - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.16 Consensus Target Price from Analysts - Defense World
0.03%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):